Company Search:
Advanced Search
Sponsored Links
Medmira Inc. Company Snapshot
Medmira Inc. operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medmira Inc. with three other pharmaceutical manufacturers in North America: Nymox Pharmaceutical Corp (2015 sales of 3.56 million Canadian Dollars [US$2.71 million] of which 100% was Pharmaceuticals), Vermillion Inc of the United States ($2.18 million of which 100% was Novel Diagnostic Test), and American Cannabis Company Inc which is also based in the United States ($2.80 million ).

Sales Analysis. Medmira Inc. reported sales of C$4.05 million (US$3.09 million) for the fiscal year ending July of 2015. This represents an increase of 60.3% versus 2014, when the company's sales were C$2.53 million. This was the fourth straight year of sales growth at Medmira Inc..
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Medmira Inc.
  Stock Performance Chart for Medmira Inc.
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): .04
(Figures in Canadian Dollars)
1 Week 0.0%   13 Weeks -12.5%  
4 Weeks 0.0%   52 Weeks -41.7%  
Medmira Inc. Key Data:
  Ticker: MIR Country: Canada
  Exchanges: VEN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2015 Sales 4,052,341
(Year Ending Jan 2016).
Employees: N/A
  Currency: Canadian Dollars Market Cap: 23,042,751
  Fiscal Yr Ends: July Shares Outstanding: 658,364,320
  Share Type: Common Closely Held Shares: 476,978,500
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.